PatentBrief

Surgical Tool That Combines Energy Treatment and Stapling

CILAG's patent details a surgical instrument that applies therapeutic energy to tissue, monitors its properties, then deploys staples, adapting the stapling based on the initial energy treatment and monitoring.

Granted 2025activeExpires 2040Owned by CILAG GMBH INTInvented by FIEBIG KEVIN M, WORTHINGTON SARAH A, MASTROIANNI NINA + 2 more

Original patent title: “Method for tissue treatment by surgical instrument

What this patent covers

The actual claim

This patent describes a method for treating tissue using a surgical instrument that combines two main actions: delivering therapeutic energy and deploying staples. In a first phase, the instrument uses at least one electrode to deliver energy to the tissue, while simultaneously monitoring a 'first tissue property'. The instrument then switches to a 'second phase' to deploy staples from a staple cartridge. This switch happens if specific conditions are met. Crucially, the parameters for the stapling phase are adjusted based on the measurements of the 'first tissue property' taken during the energy phase. A 'second tissue property', different from the first, is also monitored during the stapling phase. For example, a surgeon might use this instrument to seal blood vessels with energy while monitoring tissue impedance, then staple the tissue, with the stapling force adjusted based on the initial impedance readings, and monitor tissue thickness during stapling.

What this patent does NOT cover

The boundaries

  • Does not cover surgical instruments that only deliver therapeutic energy without also deploying staples.
  • Does not cover surgical instruments that only deploy staples without an initial energy treatment phase.
  • Does not cover instruments that fail to monitor at least two different tissue properties across the two surgical phases.
  • Does not cover instruments where the parameters of the stapling phase are not adjusted based on measurements from the energy treatment phase.
  • Does not cover instruments that do not switch from the energy phase to the stapling phase based on specific, predefined conditions.

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

What made this novel

The novelty lies in the integrated, adaptive approach: combining two distinct surgical actions (energy delivery and stapling) within one instrument, monitoring different tissue properties in each phase, and using data from the first phase to intelligently inform and adjust the parameters of the second phase.

Method for tissue treatment by…(Primary claim)medical devicessurgical instrumentshealthcarerobotics

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Advanced electrosurgical staplers

02

Integrated surgical cutting and sealing devices

03

Robotic surgical systems with adaptive tissue interaction

04

Endoscopic surgical instruments combining multiple functions

Why it matters

The bigger picture

Combining energy delivery and stapling into a single, adaptive instrument can streamline surgical procedures. By monitoring tissue properties and adjusting subsequent actions, this method aims to improve precision and safety. Such integration can potentially reduce complications and enhance patient outcomes in various surgical specialties.

Filed

December 2, 2020

Granted

November 18, 2025

Market context

Who's building on this

Companies in this space

CILAG GMBH INT, an affiliate of Johnson & Johnson's Ethicon surgical division, is a major player in this space, developing advanced surgical instruments. Other large medical device companies like Medtronic and Stryker also continuously innovate in integrated surgical tools, seeking to combine functions and enhance procedural intelligence.

Market impact

The development of integrated surgical instruments, like the one described, has driven a trend towards more efficient and precise surgical workflows. This patent contributes to a market where devices can adapt to real-time tissue conditions, potentially leading to fewer surgical steps, reduced operating times, and improved patient safety. It encourages competition in developing smarter, multi-functional tools for minimally invasive surgery.

Claim 1 — Plain English

What this patent covers

This patent describes a method for treating tissue using a surgical instrument that combines two main actions: delivering therapeutic energy and deploying staples. In a first phase, the instrument uses at least one electrode to deliver energy to the tissue, while simultaneously monitoring a 'first tissue property'. The instrument then switches to a 'second phase' to deploy staples from a staple cartridge. This switch happens if specific conditions are met. Crucially, the parameters for the stapling phase are adjusted based on the measurements of the 'first tissue property' taken during the energy phase. A 'second tissue property', different from the first, is also monitored during the stapling phase. For example, a surgeon might use this instrument to seal blood vessels with energy while monitoring tissue impedance, then staple the tissue, with the stapling force adjusted based on the initial impedance readings, and monitor tissue thickness during stapling.

The clever bit

The novelty lies in the integrated, adaptive approach: combining two distinct surgical actions (energy delivery and stapling) within one instrument, monitoring different tissue properties in each phase, and using data from the first phase to intelligently inform and adjust the parameters of the second phase.

What it does not cover

  • Does not cover surgical instruments that only deliver therapeutic energy without also deploying staples.
  • Does not cover surgical instruments that only deploy staples without an initial energy treatment phase.
  • Does not cover instruments that fail to monitor at least two different tissue properties across the two surgical phases.
  • Does not cover instruments where the parameters of the stapling phase are not adjusted based on measurements from the energy treatment phase.
  • Does not cover instruments that do not switch from the energy phase to the stapling phase based on specific, predefined conditions.

Patent Journey

From filing to today

Patent Filed

2020

Patent Granted

2025 · 5yr after filing

Highly Cited

10,346 patents cite this

Active Today

2026

Expires

2040

PatentBrief Score

Impact Score

60/ 100

Strong

Citation count

40/40

Highly cited

Claim breadth

0/20

Narrow claims

Recency

20/20

Granted within 5 years

Assignee scale

0/20

Independent or smaller assignee

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Claim text not yet imported for this patent.

Citations

Patent lineage

Cited by later patents

10,346

later patents that build on this invention

View patents →

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 12564871 · 2026

A Fixture for Cleaning Showerheads with Multiple Separate Chambers

This patent describes a cleaning device for showerheads that uses a fixture with three or more separate internal compartments and channels to direct cleaning fluid to the showerhead's upper surfaces.

ASM IP HOLDING BV

US 12324579 · 2025

Surgical Stapler Battery Health Check During Operation

This patent describes a powered surgical stapler that can detect if some of its rechargeable battery cells are damaged while it's actually firing staples, helping ensure the procedure finishes safely.

CILAG GMBH INT

US 11918209 · 2024

Real-Time Surgical Instrument Status on Live Video During Operations

This patent describes a surgical system that shows live video from inside the body and overlays important information about the surgical tool directly onto the screen, helping surgeons operate more precisely.

CILAG GMBH INT

US 8697359 · 2014

How to Use CRISPR-Cas9 to Edit Genes in Human Cells

This patent describes a method and system for precisely altering gene expression in eukaryotic cells, including human cells, using an engineered CRISPR-Cas9 system that targets and cleaves specific DNA sequences.

Massachusetts Institute of Technology

US 4683195 · 1987

How to Make Many Copies of a Specific DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a fundamental process for making millions of copies of a specific DNA or RNA segment from a tiny sample, enabling its detection.

Cetus Corp

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Worked

Apple's 2010 patent on unlocking a device by dragging a specific graphical image along a predefined path on a touchscreen, a gesture iconic with early iPhones.

Apple Inc

Semantically similar

You might also find these interesting

SEARCH ALL

US 12324579 · 2025 · CILAG GMBH INT

Surgical Stapler Battery Health Check During Operation

US 11918209 · 2024 · CILAG GMBH INT

Real-Time Surgical Instrument Status on Live Video During Operations

US 5825352 · 1998 · Logitech Inc

How Touchpads Detect Two Fingers for Clicks and Drags

US 2495429 · 1950 · Raytheon Manufacturing Co

The Microwave Oven — Invented When a Radar Engineer Melted a Chocolate Bar

Same assignee

More from CILAG GMBH INT

View all →
US 12324579·2025

Surgical Stapler Battery Health Check During Operation

US 11918209·2024

Real-Time Surgical Instrument Status on Live Video During Operations

Patent monitoring

Get notified when CILAG GMBH INT files a new patent

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: May 27, 2026 · PatentBrief is not a law firm and this is not legal advice.